Explore the words cloud of the StarT project. It provides you a very rough idea of what is the project "StarT" about.
The following table provides information about the project.
|Coordinator Country||Belgium [BE]|
|Total cost||3˙776˙714 €|
|EC max contribution||3˙776˙714 € (100%)|
1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
|Duration (year-month-day)||from 2018-10-01 to 2022-09-30|
Take a look of project's partnership.
|1||UNIVERSITEIT GENT||BE (GENT)||coordinator||768˙960.00|
|2||STICHTING KATHOLIEKE UNIVERSITEIT||NL (NIJMEGEN)||participant||531˙239.00|
|3||FONDAZIONE TELETHON||IT (ROMA)||participant||522˙999.00|
|4||NEWCELLS BIOTECH LIMITED||UK (NEWCASTLE UPON TYNE)||participant||303˙172.00|
|5||UNIVERSITY COLLEGE LONDON||UK (LONDON)||participant||303˙172.00|
|6||UNIVERSITY OF LEEDS||UK (LEEDS)||participant||303˙172.00|
|7||THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN||IE (DUBLIN)||participant||274˙684.00|
|8||PROQR THERAPEUTICS NV||NL (LEIDEN)||participant||265˙619.00|
|9||EBERHARD KARLS UNIVERSITAET TUEBINGEN||DE (TUEBINGEN)||participant||252˙788.00|
|10||AGENCIA ESTATAL CONSEJO SUPERIOR DEINVESTIGACIONES CIENTIFICAS||ES (MADRID)||participant||250˙904.00|
|11||20MED THERAPEUTICS BV||NL (ENSCHEDE)||partner||0.00|
|12||EUROPEAN VISION INSTITUTE - EEIG||BE (BRUXELLES)||partner||0.00|
|13||F. HOFFMANN-LA ROCHE AG||CH (BASEL)||partner||0.00|
|14||Fighting Blindness||IE (Dublin)||partner||0.00|
|15||INTERNATIONAL RETINITIS PIGMENTOSA ASSOCIATION||CH (ZURICH)||partner||0.00|
StarT will create an interdisciplinary and intersectorial European training network focusing on different aspects of autosomal recessive Stargardt disease (STGD1), a frequent inherited blinding disorder that affects an estimated 925,000 persons worldwide. StarT research aims to uncover the regulation of its disease gene ABCA4 and its missing heritability, in order to develop novel treatments. StarT training will give young researchers unparalleled training opportunities in outstanding vision research groups with unique expertise in omics technologies, bio-informatics, stem cell biology, animal models of disease, and therapeutics, providing each ESR with the necessary competences in state-of-the-art academic and industrial research. STGD1 is due to ABCA4 mutations, however up to 35% of STGD1 cases carries one or no ABCA4 coding mutation. New unconventional classes of ABCA4 mutations were recently discovered by us, the significance of which largely remains elusive. In order to understand the mechanisms triggered by these missing ABCA4 mutations and to design new therapies for STGD1 cases, challenging research questions will be addressed by the integration of unique skills from this network. Early-Stage Researchers will perform cutting edge research using innovative and interdisciplinary approaches: (functional) genomics and transcriptomics, bio-informatics, CRISPR/Cas9 genome editing, generation of stem cell and animal disease models and design of new treatments. The training objectives will be met through academic and industrial training-by-research via individual research projects, secondments, and network-wide training sessions.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "START" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "START" are provided by the European Opendata Portal: CORDIS opendata.